Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 7 min ago
PreprintLicence not statedmedRxiv

Treatment of ANCA-Associated Vasculitis With Avacopan: Results of the ADVOCATE Trial After Readjudication of the Primary Endpoint

  • D. Jayne
  • P. A. Merkel1
  • X. Tang
  • Z. S. Wallace
  • C. P. Norris
  • N. Hayden
  • S. Bhatta
  • R. D. Lopes
  • A. Stallings
  1. 1Division of Rheumatology, Department of Medicine, Division of Epidemiology, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvan
Read full textPDFDOICite

Related

  1. Real‐World Use of Avacopan in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Early and Long‐Term Clinical, Renal, and Patient‐Reported Outcomes in an Italian Rheumatology–Nephrology Network
    Luca Quartuccio, Elena Treppo, Miriam Isola +30
    ACR open rheumatologyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Hepatobiliary Adverse Events Associated With Avacopan: Analysis of the JADER Database
    MASAKI FUJIWARA, KAZUMASA KOTAKE, YUKI UEMICHI +1
    In VivoPeer-reviewedCC BY-NC-ND 4.0Full textPharmacology & toxicologyPMC
  3. Editorial: Comprehensive insights into ANCA vasculitis: from immunopathology to treatment strategies
    Ligia Gabrie, Alan D. Salama, Reza Zonozi +1
    Frontiers in MedicinePeer-reviewedCC BYFull textGeneral medicineDOAJ
  4. Successful Treatment with Rituximab in a Patient with Clinically Suspected Small-vessel Primary Central Nervous System Vasculitis Refractory to Cyclophosphamide Pulse Therapy
    Takuya Okamoto, Kazuki Yokokawa, Bungo Hirose +3
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
  5. Biomarkers in ANCA-Associated Vasculitis-Associated Interstitial Lung Disease: A Scoping Review
    Tommaso Pianigiani, Akter Dilroba, Michael McConville +9
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@misc{jayne2026treatment,
  title = {{Treatment of ANCA-Associated Vasculitis With Avacopan: Results of the ADVOCATE Trial After Readjudication of the Primary Endpoint}},
  author = {D. Jayne and P. A. Merkel and X. Tang and Z. S. Wallace and C. P. Norris and N. Hayden and S. Bhatta and R. D. Lopes and A. Stallings},
  howpublished = {medRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.16.26363171},
  url = {https://www.medrxiv.org/content/10.64898/2026.09.16.26363171v1},
}
RIS
TY  - UNPB
TI  - Treatment of ANCA-Associated Vasculitis With Avacopan: Results of the ADVOCATE Trial After Readjudication of the Primary Endpoint
AU  - D. Jayne
AU  - P. A. Merkel
AU  - X. Tang
AU  - Z. S. Wallace
AU  - C. P. Norris
AU  - N. Hayden
AU  - S. Bhatta
AU  - R. D. Lopes
AU  - A. Stallings
PY  - 2026
DA  - 2026/09/16
PB  - medRxiv
DO  - 10.64898/2026.09.16.26363171
UR  - https://www.medrxiv.org/content/10.64898/2026.09.16.26363171v1
ER  -